# Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome

> **NCT02067910** · PHASE3 · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 80 (actual)

## Conditions studied

- Sjögren's Syndrome

## Interventions

- **DRUG:** Abatacept SC

## Key facts

- **NCT ID:** NCT02067910
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2019-02
- **Final completion:** 2019-08
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2019-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02067910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02067910, "Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02067910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*